TY - CONF T1 - Bone metabolism biomarkers in men with advanced prostate cancer (PC) and bone metastases treated with denosumab versus zoledronic acid (ZA). JO - Journal of Clinical Oncology PY - 2015/03/01 AU - Smith MR AU - Brown JE AU - Fizazi K AU - Klotz L AU - Marx GM AU - Wang H AU - Warner D AU - Lipton A ED - DO - DOI: 10.1200/jco.2015.33.7_suppl.267 PB - American Society of Clinical Oncology (ASCO) VL - 33 IS - 7_suppl SP - 267 EP - 267 Y2 - 2024/12/21 ER -